GuerbetCompany Review & Valuation

GBT
Euronext Paris
Latest Price
31.60EUR
Market Capitalization
398.03mEUR

About Guerbet SA

Guerbet SA engages in the research, development, production, and sale of contrast media products for medical imaging, and interventional imaging primarily in the therapeutic areas of oncology, cardiology, and neurology worldwide. The company's products for the CT and Cath Lab examinations include XeShow more netix, Hexabrix, Telebrix, Conray, MD-Gastroview, and Micropaque; and Optiray/Optiject/Ultraject, as well as Ultraject/Optiject prefilled syringes. Its products for the magnetic resonance imaging (MRI) examinations comprise Dotarem, Artirem, and Optimark. The company also provides Lipiodol Ultra Fluid and Patent Blue V products for use in interventional radiology field; and imaging solutions and services, such as injectors and dedicated disposables, non-dedicated disposables, urology, digital services, and others. In addition, it offers medical devices comprising Vectorio, a mixing and injection system for trans-arterial chemo-embolization. The company distributes its products through distributors and license-holders primarily to hospitals, clinics, radiology centers, and purchasing pools, as well as wholesalers. Guerbet SA was founded in 1926 and is headquartered in Villepinte, France. Show less

Industry
Medical Devices
HQ Location
Villepinte, France
Wikipedia

Stock Price

Price data not available for Guerbet.

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top